Is cen breaking out check out the chart its come to a pinical on a symetrical triangle and moved up, so looking good for the new yr

I cannot see a symetrical triangle. However I believe the share has legs for 2004.

It was a 2.5 bagger in 2003, has attracted institutional interest, and a product base that appeals to the mass market.

Movement through the various Clinical Phase trials is also very encouraging.

Costs have been cut, and all the brokers expressing an opinion have ALL moved to BUY recommendations - two of them in December alone.

Along with the Glaxo Smith Kline relationship and their ability to get products to market on a mass scale, this looks like an excellent one to accumulate I reckon. Another 2.5 bagger in 2004 would be a good.

I also notice that the price is respecting the 40 RSI level which is good news ;-)